Stem cells don't repair tissue directly. They send signals. Exosomes are those signals — nano-sized vesicles packed with the molecular instructions that tell your body to reduce inflammation, rebuild tissue, and regenerate. Here's why they matter.
For decades, researchers assumed stem cells repaired tissue by differentiating into new cells — replacing damaged cartilage with new cartilage, damaged muscle with new muscle. The reality is more elegant: stem cells primarily work by secreting signals that instruct the body's own cells to repair themselves.
Exosomes are the primary vehicle for those signals. They are nano-sized vesicles (30–150 nanometers) that bud off from cell membranes and carry a cargo of microRNA, proteins, and lipids. When they fuse with a recipient cell, they deliver their payload — reprogramming the cell's behavior.
In the context of regenerative medicine, MSC-derived exosomes carry anti-inflammatory signals, pro-regenerative growth factors, and RNA sequences that activate tissue repair pathways. They are, in effect, the active ingredient in stem cell therapy.
Exosomes carry microRNA, proteins, and lipids that reprogram recipient cells — turning down inflammatory pathways and turning up repair signals. They are the body's native messaging system, amplified.
A single MSC secretes thousands of exosomes. When delivered therapeutically, they flood the target tissue with regenerative signals — far more than the cells themselves could produce in situ.
Exosomes are injected directly into the affected joint or tissue. Their nano-scale size allows them to penetrate cell membranes and reach intracellular targets that larger molecules cannot.
When used alongside Wharton's Jelly MSC therapy, exosomes extend the regenerative signal — continuing to instruct tissue repair long after the initial treatment.
Wharton's Jelly MSCs are living cells that engraft in the target tissue and continue producing regenerative signals for weeks. Exosomes are the concentrated signaling payload — they act immediately, flooding the tissue with repair instructions from the moment of injection.
Used together, they create a two-phase regenerative response: exosomes provide the immediate signal burst, while MSCs sustain the regenerative environment over time. This is why our combined protocols consistently outperform either therapy alone.
Exosomes are nano-sized extracellular vesicles (30–150 nanometers) secreted by cells — including mesenchymal stem cells. They carry proteins, lipids, and RNA that act as molecular signals, instructing recipient cells to reduce inflammation, repair tissue, and regenerate. Think of them as the messaging system that tells your body what to do.
No. Stem cells are living cells that can differentiate and divide. Exosomes are cell-free vesicles — they carry the signaling molecules that stem cells produce, without the cells themselves. This makes them easier to standardize, store, and administer, with a lower risk of immune reaction.
Exosome therapy is used alongside stem cell protocols for joint degeneration, soft-tissue injuries, chronic inflammation, and recovery optimization. It is not a standalone treatment for systemic diseases.
Exosomes are typically administered via targeted injection to the affected area, often in combination with Wharton's Jelly MSC therapy. The procedure is performed by a licensed nurse practitioner in your home.
Exosome therapy for musculoskeletal conditions is not FDA-approved as a finished drug product. It is administered as part of a physician-supervised regenerative protocol. All products we use are sourced from AATB-accredited tissue banks and tested for safety and potency.
We'll route you to the right clinician and the right program. If you're not a fit for any of them, we'll tell you that too. That's the whole point.
Regenerative therapies are provided as a concierge medical service following an in-person consultation. We do not sell stem cell or exosome products online.
